A detailed history of Charles Schwab Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Charles Schwab Trust CO holds 629 shares of AMGN stock, worth $176,164. This represents 0.02% of its overall portfolio holdings.

Number of Shares
629
Previous 1,729 63.62%
Holding current value
$176,164
Previous $540,000 62.59%
% of portfolio
0.02%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$309.38 - $337.38 $340,318 - $371,118
-1,100 Reduced 63.62%
629 $202,000
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $80,138 - $97,389
305 Added 21.42%
1,729 $540,000
Q1 2024

Apr 12, 2024

SELL
$268.87 - $324.56 $5,108 - $6,166
-19 Reduced 1.32%
1,424 $404,000
Q3 2023

Oct 19, 2023

SELL
$218.65 - $271.46 $21,865 - $27,145
-100 Reduced 6.48%
1,443 $387,000
Q4 2022

Jan 26, 2023

SELL
$229.03 - $291.01 $28,399 - $36,085
-124 Reduced 7.44%
1,543 $0
Q3 2022

Oct 18, 2022

SELL
$224.46 - $253.15 $29,179 - $32,909
-130 Reduced 7.23%
1,667 $376,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $29,992 - $33,376
130 Added 7.8%
1,797 $437,000
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $6,578 - $7,277
-30 Reduced 1.77%
1,667 $403,000
Q3 2021

Oct 08, 2021

SELL
$212.27 - $248.7 $1,910 - $2,238
-9 Reduced 0.53%
1,697 $361,000
Q2 2021

Aug 04, 2021

BUY
$233.58 - $259.14 $31,066 - $34,465
133 Added 8.46%
1,706 $416,000
Q1 2021

Apr 14, 2021

SELL
$221.91 - $258.6 $98,749 - $115,077
-445 Reduced 22.05%
1,573 $392,000
Q4 2020

Jan 14, 2021

BUY
$216.38 - $257.67 $9,520 - $11,337
44 Added 2.23%
2,018 $464,000
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $17,598 - $19,571
75 Added 3.95%
1,974 $502,000
Q1 2020

Apr 09, 2020

SELL
$182.24 - $241.7 $911 - $1,208
-5 Reduced 0.26%
1,899 $385,000
Q3 2019

Nov 15, 2019

BUY
$174.11 - $208.62 $331,505 - $397,212
1,904 New
1,904 $368,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Charles Schwab Trust CO Portfolio

Follow Charles Schwab Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Trust CO with notifications on news.